DeepMed Research

Chinese Academy of Medical Sciences Peking Union Medical College Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC

Phase 2

Conditions: Breast Cancer Female
HER2-positive Breast Cancer
Hormone Receptor Positive Malignant Neoplasm of Breast
Metastatic Breast Cancer
Breast Diseases
Hormone Receptor Positive Tumor

Interventions: Drug: Pyrotinib
Drug: Trastuzumab
Drug: Aromatase inhibitor

First Posted Date: 2019-04-10

Last Posted Date: 2019-04-10

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 250

Registration Number: NCT03910712

Persistent Cervical HPV Infection With Clearance and Vaginal Microbiota

Conditions: HPV-Related Squamous Cell Carcinoma

Interventions: Other: The participants were assigned to different groups according to the results of HPV detection.

First Posted Date: 2019-03-29

Last Posted Date: 2019-08-29

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 240

Registration Number: NCT03895866

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors

Phase 2

Completed

Conditions: Liver Neoplasm Malignant Primary
Biomarker
Cholangiocarcinoma
Combinational Immunotherapy

Interventions: Drug: Lenvatinib plus Pembrolizumab

First Posted Date: 2019-03-29

Last Posted Date: 2023-03-29

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 32

Registration Number: NCT03895970

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Real-world Study for Patients With Advanced Hepatobiliary Tumors

Recruiting

Conditions: Five-year Survival Rate
Progression-free Survival
Overall Survival
Disease Control Rate
Quality of Life
Objective Response Rate
Duration of Response

Interventions: Drug: Precision oncology including targeted therapy and immunotherapy

First Posted Date: 2019-03-27

Last Posted Date: 2023-03-29

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 3000

Registration Number: NCT03892577

Locations: 🇨🇳
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing, Beijing, China

Diagnostic and Imaging Indicators of Immunocardiomyopathic Patients

Conditions: Autoimmune Diseases

First Posted Date: 2019-03-21

Last Posted Date: 2019-03-21

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 100

Registration Number: NCT03885375

Locations: 🇨🇳
Peking Union Medical College Hostipal, Beijing, Beijing, China

Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer

Phase 2

Conditions: Locally Advanced Pancreatic Cancer

Interventions: Drug: Nab-paclitaxel and S-1

First Posted Date: 2019-03-21

Last Posted Date: 2020-03-10

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 60

Registration Number: NCT03885219

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

An Analysis of the Quality of Life and Sexual Quality of Life of Cervical Cancer Radiotherapy Patients

Conditions: Cervical Cancer
Radiotherapy Side Effect
Quality of Life

First Posted Date: 2019-03-21

Last Posted Date: 2019-06-25

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 200

Registration Number: NCT03885505

Systemic Prevention and Management for Perioperative Hypothermia and Its Effect on Patients Outcome

Not Applicable

Conditions: Hypothermia; Anesthesia

Interventions: Combination Product: high risk warm
Other: passive warming
Combination Product: moderate risk warm
Combination Product: low risk warm

First Posted Date: 2019-03-18

Last Posted Date: 2019-03-18

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 800

Registration Number: NCT03878901

Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH

Phase 4

Conditions: Paroxysmal Nocturnal Hemoglobinuria

Interventions: Drug: sirolimus

First Posted Date: 2019-03-07

Last Posted Date: 2019-03-08

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 40

Registration Number: NCT03866681

Locations: 🇨🇳
Peking union medical college hospital, Beijing, China

The Training and Evaluate Effect on Clinical Airway Management for Novices.

Not Applicable

Conditions: Education
Bronchoscopy
Airway Management

Interventions: Behavioral: Novice

First Posted Date: 2019-02-27

Last Posted Date: 2019-03-06

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 150

Registration Number: NCT03856073

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy